The evolution of selective estrogen receptor modulators in osteoporosis therapy

Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis

(2013) Catherine MacLean et al.   ANNALS OF INTERNAL MEDICINE

Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats

(2011) Barry S. Komm et al.   BONE

Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older

(2011) Andrew N. Freedman et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-Term Benefits of 5 Years of Tamoxifen: 10-Year Follow-Up of a Large Randomized Trial in Women at Least 50 Years of Age With Early Breast Cancer

(2011) Allan Hackshaw et al.   JOURNAL OF CLINICAL ONCOLOGY

The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor   and Cyclin D1

(2011) J. S. Lewis-Wambi et al.   MOLECULAR PHARMACOLOGY

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

(2011) S. L. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Effect of Raloxifene on All-cause Mortality

(2010) Deborah Grady et al.   AMERICAN JOURNAL OF MEDICINE

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis

(2010) Claus Christiansen et al.   BMC MUSCULOSKELETAL DISORDERS

Lasofoxifene and Cardiovascular Events in Postmenopausal Women With Osteoporosis

(2010) Kristine Ensrud et al.   CIRCULATION

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women

(2010) A. Z. LaCroix et al.   JNCI-Journal of the National Cancer Institute

Management of osteoporosis in postmenopausal women

(2010) &NA;   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women

(2010) Risa Kagan et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial

(2010) Steven R. Goldstein et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Lasofoxifene in Postmenopausal Women with Osteoporosis

(2010) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

(2010) T. J. de Villiers et al.   OSTEOPOROSIS INTERNATIONAL

Osteonecrosis of the Jaw and the Role of Bisphosphonates: A Critical Review

(2009) Stuart L. Silverman et al.   AMERICAN JOURNAL OF MEDICINE

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®

(2009) John A. Kanis et al.   BONE

Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile

(2009) Rogerio A. Lobo et al.   FERTILITY AND STERILITY

Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women

(2009) David F. Archer et al.   FERTILITY AND STERILITY

Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women

(2009) Robert Lindsay et al.   FERTILITY AND STERILITY

Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy

(2009) James H. Pickar et al.   FERTILITY AND STERILITY

Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: Insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens

(2009) Ken C.N. Chang et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Bazedoxifene, a selective estrogen receptor modulator

(2009) David F. Archer et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens

(2009) JoAnn V. Pinkerton et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

The Pairing of a Selective Estrogen Receptor Modulator, Bazedoxifene, with Conjugated Estrogens as a New Paradigm for the Treatment of Menopausal Symptoms and Osteoporosis Prevention

(2008) Yogendra Kharode et al.   ENDOCRINOLOGY

Effects of Various Selective Estrogen Receptor Modulators with or without Conjugated Estrogens on Mouse Mammary Gland

(2008) Bryan J. Peano et al.   ENDOCRINOLOGY

Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*

(2008) Stuart L Silverman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Tamoxifen Use and Osteoporotic Fracture Risk: A Population-Based Analysis

(2008) Andrew L. Cooke et al.   JOURNAL OF CLINICAL ONCOLOGY

Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland

(2008) Judy S. Crabtree et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Differential Biochemical and Cellular Actions of Premarin Estrogens: Distinct Pharmacology of Bazedoxifene-Conjugated Estrogens Combination

(2008) Thomas J. Berrodin et al.   MOLECULAR ENDOCRINOLOGY